 |
| SEPTEMBER
29, 2026 |
| Regional
intelligence on Drugs, Diagnostics,
Devices & Digital Health |
|
|
|
* may need subscription to view |
 |
BIG4BIO
CEO WEEKLY Q&A:
Kate
Torchilin, Ph.D., M.B.A., CEO and
President, Mirai Bio |
| In this
CEO Q&A, Torchilin discusses the
delivery bottleneck that inspired Mirai's
founding, what differentiates its
integrated LNP platform, the milestone
that took a partner program from concept
to IND-enabling studies in under ten
months, and leading within the Flagship
Pioneering ecosystem. More |
|
|
- Arrowhead
Pharmaceuticals: Will Host a Webinar With
Interim Clinical Data From a Phase 1/2a Study
of ARO-MAPT for the Treatment of Alzheimer’s
Disease and Other Tauopathies More
- GATC
Health: Derisq Named One of The Scientist's
2026 Top Innovations More
- Global
Neurosciences Institute & SetPoint
Medical: Performs First SetPoint System
Procedures in Southern New Jersey More
- Immix
Biopharma: 89% Complete Response Rate at
Interim Update Across All NEXICART-2
Patients, With MRD-Negativity Indicating
Potential to Reach up to 98% Complete
Response Rate, Supporting Potential
Best-in-Class Therapy for
Relapsed/Refractory AL Amyloidosis More
- NorthStrive
Biosciences: Partners With Charles River
Laboratories to Advance Its EL-22 and EL-32
Engineered Probiotic Programs More
- Tarsus:
Plans to Present 11 Abstracts Highlighting New
Insights in Demodex Blepharitis, Ocular
Rosacea and the Real-World Impact of XDEMVY at
the American Academy of Optometry 2026 Annual
Meeting
More
|
|
- Drs.
Steven Dubinett From UCLA and Lecia Sequist
From Mass General/Harvard Receive Inaugural
2026 Research Awards for Transformative Work
in Early Lung Cancer Detection More
- Immix
Biopharma: Pricing of $125 Million
Underwritten Offering of Common Stock More
- OSI
Systems: Receives Orders of $7 Million for
Electronic Sub-Assemblies More
- UCLA
Health: Dr. Tue Te Receives 5-Year NIH Grant
to Investigate Early Vocal and Sleep Signals
of Cognitive Decline More
|
|
 |
| The
future of advanced therapies:
Explore challenges and
opportunities shaping patient
access, site-of-care expansion and
commercialization. |
| Access the
Report → |
|
|
- Big4Bio CEO Weekly Q&A: Kate
Torchilin, Ph.D., M.B.A., CEO and President,
Mirai Bio More
- Biotech & Pharma Updates | September 28,
2026 More
- Subscribe to LifeSci Startup for
Updates on US Startups More
- The Biotech Startups Podcast: How Teaching
High School Prepares You to Run a Company
Podcast
|
|
-
|
| Life
Sciences Talent and Consulting
Strategist George Quinn Named
Partner, Fractional Talent at
Slone Partners |
|
Learn More
→ |
|
|
- Fetal
Surgeon Payam Saadai, MD, to Join Rady
Children's Health Orange County More
- MiniMed: Appoints Sheila Denton as General
Counsel & Corporate Secretary More
- OPPORTUNITY: Vice President, Business
Development, Remote More
- OPPORTUNITY: Director of Compliance, Remote
More
- Slone Partners: Beyond the Org Chart
- Redefining Leadership Roles After an
Acquisition More
|
|
|
DISCOVER COMPANIES |
|
Big4Bio: Los Angeles Life Science
Company Directory |
|
Locate a specific company or
explore new companies in life
science. |
|
Explore
our Company Directory
|
Provided courtesy
of
 |
|
|
|
 |
|
|
|
You are
receiving this email because
you signed up for one of our
newsletters at Big4Bio.com,
signed up at one of our
partner or sponsor events,
or given as a gift
subscription by your firm or
organization. Unsubscribe
Big4Bio:Los
Angeles, all rights reserved
2026
© 2026
Big4Bio, a division of
BigBio Communications. All
rights reserved.
|
|
|
|
|
